SCHEMBL2366829

SCHEMBL2366829

O=C(c1ccc(N2CCOC2=O)nc1)N1CCN(c2ncc(C3CC3)cc2C2CC2)CC1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 3/20 0.40
HPGD P15428 2/20 0.40
HSD17B10 Q99714 2/20 0.40
POLB P06746 1/20 0.40
ALOX15 P16050 1/20 0.40
VNN1 O95497 1/20 0.38
FASN P49327 1/20 0.37
ADRA1A P35348 4/20 0.36
SLC6A7 Q99884 1/20 0.36
LMNA P02545 1/20 0.36
DGAT1 O75907 2/20 0.36
PRKAA2 P54646 1/20 0.35
BTK Q06187 2/20 0.35
MGLL Q99685 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2366042 0.90 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL2366466 0.90 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL2366220 0.89 DGAT1 (0.44) HPGDSLC6A7DGAT1BTK
SCHEMBL2366701 0.87 ALDH1A1 (0.42) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL2366875 0.86 LMNA (0.36) ALDH1A1KDM4EFASNLMNABTK
SCHEMBL14687005 0.84 MEN1 (0.39) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL12240528 0.83 ALDH1A1 (0.38) ALDH1A1KDM4EHPGDHSD17B10POLB
Hydrochloric Acid SCHEMBL2380578 0.82 ALDH1A1 (0.37) ALDH1A1KDM4EHPGDHSD17B10POLB
Hydrochloric Acid SCHEMBL2380583 0.82 ALDH1A1 (0.37) ALDH1A1KDM4EHPGDHSD17B10POLB
SCHEMBL2366015 0.82 ALDH1A1 (0.37) ALDH1A1KDM4EHPGDHSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2364975-B1 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE MITSUBISHI TANABE PHARMA CORP (JP) 2013-06-12 EP disclosed
US-8354401-B2 Oxazolidinone amide aromatic compounds for supressing MMP-9 production MITSUBISHI TANABE PHARMA CORPORATION (JP) 2013-01-15 US disclosed
US-8354401-B2 Oxazolidinone amide aromatic compounds for supressing MMP-9 production MITSUBISHI TANABE PHARMA CORPORATION (JP) 2013-01-15 US disclosed
US-8354401-B2 Oxazolidinone amide aromatic compounds for supressing MMP-9 production MITSUBISHI TANABE PHARMA CORPORATION (JP) 2013-01-15 US disclosed
US-20110263571-A1 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-10-27 US disclosed
US-20110263571-A1 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-10-27 US disclosed
US-20110263571-A1 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-10-27 US disclosed
EP-2364975-A1 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE Mitsubishi Tanabe Pharma Corporation (JP) 2011-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263571-A1 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE MMP9, MMP10, MMP2 ALDH1A1 598/4885KDM4E 1064/4885HPGD 135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.